Research - Boston, Massachusetts, United States
Differentiated Therapeutics (DXTX) has built the first end-to-end discovery engine for Targeted Protein Degradation (TPD) which drives the discovery and optimization of novel protein degraders designed to eliminate the genetically defined drivers of disease
Gmail
Varnish
Wix
Microsoft Office 365
Google Cloud Hosting